Search research articles
Contact Us
Filters
Showing results (421-430 of 447) with videos related to
Page
of 45
Sort By:
Journal of Immunology Research
|
December 7, 2020
Intranigral Administration of <i>β</i>-Sitosterol-<i>β</i>-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra
Claudia Luna-Herrera, Irma A Martínez-Dávila, Luis O Soto-Rojas, et al.
Cancer Cell
|
September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Journal for Immunotherapy of Cancer
|
October 10, 2025
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors
Peter J Madsen, Anna Melissa Schlitter, Carina Flemmig, et al.
Cancers
|
September 9, 2023
Clinico-Pathological Features, Outcomes and Impacts of COVID-19 Pandemic on Patients with Early-Onset Colorectal Cancer: A Single-Institution Experience
Daniel Martinez-Perez, David Viñal, Jesús Peña-Lopez, et al.
The Lancet. Healthy Longevity
|
December 15, 2022
Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study
Patricio Lopez-Jaramillo, Diego Gomez-Arbelaez, Daniel Martinez-Bello, et al.
Cell Reports
|
August 9, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas
Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma
Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Nature Communications
|
August 14, 2025
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers
Alberto D Guerra, Smita Matkar, Christina Acholla, et al.
Cancer Cell
|
January 23, 2026
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
Triantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, et al.
Cancer Discovery
|
March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
Presha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Page
of 45
Search research articles
Search
Showing results (421-430 of 447) with videos related to
Sort By:
Page
of 45
Journal of Immunology Research
|
December 7, 2020
Intranigral Administration of <i>β</i>-Sitosterol-<i>β</i>-D-Glucoside Elicits Neurotoxic A1 Astrocyte Reactivity and Chronic Neuroinflammation in the Rat Substantia Nigra
Claudia Luna-Herrera, Irma A Martínez-Dávila, Luis O Soto-Rojas, et al.
Cancer Cell
|
September 13, 2017
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
Kristopher R Bosse, Pichai Raman, Zhongyu Zhu, et al.
Journal for Immunotherapy of Cancer
|
October 10, 2025
Claudin 6 is a suitable target for CAR T-cell therapy in atypical teratoid/rhabdoid brain tumors and other pediatric solid tumors
Peter J Madsen, Anna Melissa Schlitter, Carina Flemmig, et al.
Cancers
|
September 9, 2023
Clinico-Pathological Features, Outcomes and Impacts of COVID-19 Pandemic on Patients with Early-Onset Colorectal Cancer: A Single-Institution Experience
Daniel Martinez-Perez, David Viñal, Jesús Peña-Lopez, et al.
The Lancet. Healthy Longevity
|
December 15, 2022
Association of the triglyceride glucose index as a measure of insulin resistance with mortality and cardiovascular disease in populations from five continents (PURE study): a prospective cohort study
Patricio Lopez-Jaramillo, Diego Gomez-Arbelaez, Daniel Martinez-Bello, et al.
Cell Reports
|
August 9, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas
Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Biorxiv : the Preprint Server for Biology
|
January 27, 2025
Neuronal cell adhesion molecule (NRCAM) variant defined by microexon skipping is an essential, antigenically distinct, and targetable proteoform in high-grade glioma
Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins, et al.
Nature Communications
|
August 14, 2025
A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers
Alberto D Guerra, Smita Matkar, Christina Acholla, et al.
Cancer Cell
|
January 23, 2026
IFNγ-dependent metabolic reprogramming restrains an immature, pro-metastatic lymphatic state in melanoma
Triantafyllia Karakousi, Vanessa Cristaldi, Maria Luiza Lopes de Oliveira, et al.
Cancer Discovery
|
March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk Neuroblastoma
Presha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Page
of 45